apollo
0

Welcome User

Login/Sign Up

Home
Buy Medicines
Lab Tests
Doctor Consult
Circle Membership
insurance
Blogs
Contact Us
Privacy Policy
Return & Refunds
Need Help
Terms and Conditions
  1. Home
  2. Medicine

  3. Tyvalzi 30 mcg Combipack Injection 1's

Tyvalzi 30 mcg Combipack Injection 1's, Pack of 1 INJECTION
Tyvalzi 30 mcg Combipack Injection 1's, Pack of 1 INJECTION
Tyvalzi 30 mcg Combipack Injection 1's, Pack of 1 INJECTION
Tyvalzi 30 mcg Combipack Injection 1's, Pack of 1 INJECTION
Offers on medicine orders
All offers
axis icici
Written By Lakshmithulasi Yarragunta ,
Reviewed By Dr Aneela Siddabathuni , MPharma., PhD

Tyvalzi 30 mcg Combipack Injection 1's is used in the treatment of cerebral ischemic stroke. It contains sovateltide (endothelin B receptor agonist) which increases cerebral blood flow and anti-cell death activity by stimulating neural progenitor cells. Tyvalzi 30 mcg Combipack Injection 1's may cause common side effects like abdominal discomfort, vomiting, sweating and uneasiness. These side effects generally occur when administered in higher doses. However, inform your doctor immediately if you observe any such side effects. Tyvalzi 30 mcg Combipack Injection 1's should be avoided if you are allergic to it. Pregnant and breastfeeding mothers should use Tyvalzi 30 mcg Combipack Injection 1's only if prescribed by the physician. Tyvalzi 30 mcg Combipack Injection 1's is not recommended for use in children as safety is not established.

Read more
rxMedicinePrescription drug

Whats That

tooltip

Also Explore

Momverse
Ask Apollo
insurance

Composition :

SOVATELTIDE-30MCG

Manufacturer/Marketer :

Sun Pharmaceutical Industries Ltd

Consume Type :

PARENTERAL

Return Policy :

Not Returnable

Expires on or after :

About Tyvalzi 30 mcg Combipack Injection 1's

Tyvalzi 30 mcg Combipack Injection 1's belongs to the class of endothelin B receptor agonists used in the treatment of cerebral ischemic stroke. Cerebral ischemic stroke is a condition in which the lack of blood supply to the brain stops brain tissue from obtaining oxygen and nutrients, resulting in potential brain damage, neurological impairments, or death.

Tyvalzi 30 mcg Combipack Injection 1's contains sovateltide, a neural progenitor cell therapeutic agent. It works by stimulating neural progenitor cells to create neurovascular remodelling. This produces new neurons and blood vessels, thus increasing cerebral blood flow and anti-cell death activity.

Tyvalzi 30 mcg Combipack Injection 1's will be administered by a trained healthcare professional. Do not self administer. This medicine may cause side effects like abdominal discomfort, vomiting, sweating and uneasiness. These side effects generally occur when administered in higher doses. However, inform your doctor immediately if you observe any such side effects.

Tyvalzi 30 mcg Combipack Injection 1's should be avoided if you are allergic to it. Before receiving the medicine, inform your doctor if you have any medical conditions like acute or chronic subdural hematoma, subarachnoid hemorrhage, epidural hemorrhage, intracranial hemorrhage, intracerebral hematoma, or intraventricular hemorrhage, and liver/kidney disease. Also, let your doctor know if you are pregnant or breastfeeding before starting the treatment. 

Uses of Tyvalzi 30 mcg Combipack Injection 1's

Tyvalzi 30 mcg Combipack Injection 1's is used in the treatment of treatment of ischemic stroke and pulmonary arterial hypertension (PAH). The detailed uses of Tyvalzi 30 mcg Combipack Injection 1's are as follows:<br/>• Treatment of cerebral ischemic stroke: Tyvalzi 30 mcg Combipack Injection 1's treats cerebral ischemic stroke by enhancing neuroregeneration and improving blood flow to the affected area of the brain.<br/>• Pulmonary arterial hypertension (PAH): Tyvalzi 30 mcg Combipack Injection 1's can potentially alleviate Pulmonary Arterial Hypertension (PAH) by relaxing and widening pulmonary arteries, reducing blood pressure.<br/>• Neuroprotection: Tyvalzi 30 mcg Combipack Injection 1's shields brain cells from damage and enhances mitochondrial function for better energy production.<br/>

Directions for Use

• Follow your doctor's instructions on the dosage and timing of this medication.• Tyvalzi 30 mcg Combipack Injection 1's is administered by the doctor or nurse in a healthcare setting.• Do not self-administer.

Medicinal Benefits

Tyvalzi 30 mcg Combipack Injection 1's is used in the treatment of cerebral ischemic stroke. It contains sovateltide, a neural progenitor cell therapeutic agent. It works by stimulating neural progenitor cells to create neurovascular remodelling. This produces new neurons and blood vessels, thus increasing cerebral blood flow and anti-cell death activity. Tyvalzi 30 mcg Combipack Injection 1's has antioxidant, anti-inflammatory, and anti-cell death properties, which may help stroke victims regain their neurological and motor function by reducing brain cell death.

How Tyvalzi 30 mcg Combipack Injection 1's Works

Tyvalzi 30 mcg Combipack Injection 1's contains sovateltide, a neural progenitor cell therapeutic agent. It works by stimulating neural progenitor cells to create neurovascular remodelling. This produces new neurons and blood vessels, thus increasing cerebral blood flow and anti-cell death activity.

Storage

• Store in a cool and dry place away from sunlight.• Keep Tyvalzi 30 mcg Combipack Injection 1's out of the sight and reach of children.• Cold chain - To be stored in cold places at 2ºC to 8ºC.

What if I have taken an overdose of Tyvalzi 30 mcg Combipack Injection 1's

As Tyvalzi 30 mcg Combipack Injection 1's is a parenteral formulation administered by experienced medical staff, the chance of overdose may be less. However, if you think there has been an overdose or experiencing any adverse events, get medical care right away. Overdose of Tyvalzi 30 mcg Combipack Injection 1's may cause uneasiness, abdominal discomfort, and sweating.

Drug Warnings

Before taking the Tyvalzi 30 mcg Combipack Injection 1's, let your doctor know you're allergic to any ingredient. Inform your doctor about your medical history and other medications you are currently taking to rule out any potential negative effects. Inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding or if you have any other medical conditions, including active internal bleeding, current severe uncontrolled hypertension, acute or chronic subdural hematoma, subarachnoid hemorrhage, epidural hemorrhage, intracranial hemorrhage, intracerebral hematoma, or intraventricular hemorrhage, and liver/kidney disease. Tyvalzi 30 mcg Combipack Injection 1's is not recommended for use in children below 12 years of age as the safety and efficacy are not established.

Diet & Lifestyle Advise

  • Eat a diet rich in whole grains, vegetables, fruits, skinless poultry, fish, eggs, and low-fat dairy products.
  • Avoid smoking and alcohol consumption.
  • Maintain a healthy weight with proper diet and exercise.
  • Managing stress with meditation, yoga, and massage.
  • Avoid eating fried food, fast food, boxed food, canned food, and processed frozen meals.

Habit Forming

No

Therapeutic Class

CARDIOVASCULAR AGENTS
bannner image

Alcohol

Consult your doctor

No evedience available whether Tyvalzi 30 mcg Combipack Injection 1's interacts with alcohol. Please consult the doctor.

bannner image

Pregnancy

Consult your doctor

It is unknown whether Tyvalzi 30 mcg Combipack Injection 1's can be given for pregnant women. Therefore, inform your doctor if you are pregnant or planning pregnancy before receiving Tyvalzi 30 mcg Combipack Injection 1's.

bannner image

Breast Feeding

Consult your doctor

Limited information is available for use of Tyvalzi 30 mcg Combipack Injection 1's in breastfeeding mothers. Therefore, inform your doctor if you are nursing before receiving Tyvalzi 30 mcg Combipack Injection 1's.

bannner image

Driving

Caution

It is unknown whether Tyvalzi 30 mcg Combipack Injection 1's will affect the ability to drive. However, it is advised to drive only if you are alert.

bannner image

Liver

Consult your doctor

Limited information is available for the use of Tyvalzi 30 mcg Combipack Injection 1's in liver disease patients. Please consult your doctor regarding any concerns.

bannner image

Kidney

Consult your doctor

Limited information is available for the use of Tyvalzi 30 mcg Combipack Injection 1's in kidney disease patients. Please consult your doctor regarding any concerns.

bannner image

Children

Unsafe

Tyvalzi 30 mcg Combipack Injection 1's is not recommended for use in children below 12 years of age as the safety and efficacy are not established.

Have a query?

FAQs

Tyvalzi 30 mcg Combipack Injection 1's is used in the treatment of Cerebral Ishemic Stroke ( condition in which the lack of blood supply to the brain stops brain tissue from obtaining oxygen and nutrients, resulting in potential brain damage).

Tyvalzi 30 mcg Combipack Injection 1's contains sovateltide, a neural progenitor cell therapeutic agent. It works by stimulating neural progenitor cells to create neurovascular remodelling. This produces new neurons and blood vessels, thus increasing cerebral blood flow and anti-cell death activity.

Tyvalzi 30 mcg Combipack Injection 1's may cause side effects like abdominal discomfort, vomiting, sweating and uneasiness. These side effects generally occur when administered in higher doses. However, inform your doctor immediately if you observe any such side effects.

Tyvalzi 30 mcg Combipack Injection 1's will be administered intravenously by a trained health care professional. Hence donot self administer.

Inform your doctor if you have any medical conditions, including active internal bleeding, current severe uncontrolled hypertension, acute or chronic subdural hematoma, subarachnoid hemorrhage, epidural hemorrhage, intracranial hemorrhage, intracerebral hematoma, or intraventricular hemorrhage, and liver/kidney disease.

Tyvalzi 30 mcg Combipack Injection 1's should be stored in a cold places at 2°C to 8°C. Keep Tyvalzi 30 mcg Combipack Injection 1's out of the sight and reach of children.

Country of origin

India

Manufacturer/Marketer address

Sun Pharmaceutical Industries Ltd., Sun House, Cts No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063
Other Info - TYV0003

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.

Author Details

Dr Aneela SiddabathuniDoctor badge

Reviewed By

Dr Aneela Siddabathuni

MPharma., PhD

Last Updated

Aug 6, 2025 | 10:58 AM IST

Doctor imageWe provide you with authentic, trustworthy and relevant information

Reference

  1. https://link.springer.com/article/10.1007/s40267-024-01094-5
  2. https://synapse.patsnap.com/article/what-is-sovateltide-used-for
  3. https://practicalneurology.com/news/sovateltide-improved-neurologic-outcomes-for-ischemic-stroke/2470114/

Buy best C.n.s Drugs products by

whatsapp Floating Button
Buy Now
Add to Cart